Nebivolol Viatris (Nebivolol Hydrochloride)

Nebivolol Hydrochloride, the active ingredient in Nebivolol Viatris, is a beta blocker presented as a tablet for oral use. It selectively reduces elevated blood pressure in adult patients with hypertension, helping to lower cardiovascular risk.

GNH USA supplies Nebivolol Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, offering consistent quality, regulatory‑approved manufacturing and reliable logistics for global markets.

Nebivolol Viatris is a beta‑blocker indicated for the management of hypertension, acting on the cardiovascular system to lower blood pressure.

- Hypertension: reduces systolic and diastolic blood pressure, helping to control essential hypertension in adult patients.

Nebivolol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate pain in the head. - Dizziness: sensation of light‑headedness, especially on standing. - Fatigue: generalized tiredness. - Nasal congestion: blocked or runny nose. - Bradycardia: slower than normal heart rate. - Nausea: feeling of stomach upset.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Symptomatic hypotension: significant drop in blood pressure causing faintness. - Heart block: impairment of electrical conduction in the heart. - Bronchospasm: tightening of airway muscles, especially in asthmatic patients. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

Before initiating therapy with Nebivolol, clinicians should consider several safety aspects.

- Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Heart rate assessment: watch for bradycardia, especially in patients with pre‑existing conduction disorders. - Asthma or COPD caution: use with care as β‑blockade may provoke bronchospasm. - Discontinuation: avoid abrupt stopping to prevent rebound hypertension. - Hepatic impairment: dose adjustment may be required in patients with liver dysfunction. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with several medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Other β‑blockers: additive negative chronotropic effects. - Calcium‑channel blockers (verapamil, diltiazem): may cause excessive bradycardia or AV block. - Strong CYP2D6 inhibitors (paroxetine, fluoxetine): increase nebivolol plasma concentrations.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance antihypertensive effect, risking hypotension. - ACE inhibitors or ARBs: combined use can lead to pronounced blood pressure reduction. - NSAIDs: may attenuate antihypertensive response, requiring BP monitoring.